This inventor holds 1 USPTO granted patent. Top assignee: Transgene S.a.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Philippe Leissner: Innovator in Adenovirus Research
Introduction
Philippe Leissner is a notable inventor based in Caluire et Cuire, France. He has made significant contributions to the field of virology, particularly in the modification of adenoviruses. His innovative work has implications for various therapeutic applications.
Latest Patents
Leissner holds a patent for a "Modified adenovirus fibre and uses." This invention concerns an adenovirus fiber that has been modified by mutating one or several residues in the region between residues 491 and 505 of SEQ ID NO: 1. The viral particles or pseudo-particles that comprise such a fiber and their uses are central to this patent. He has 1 patent to his name.
Career Highlights
Philippe Leissner is associated with Transgene S.A., a company that focuses on developing innovative immunotherapies for cancer and infectious diseases. His work at Transgene has allowed him to explore the potential of modified adenoviruses in therapeutic settings.
Collaborations
Leissner collaborates with Valérie Legrand, contributing to advancements in their shared field of research. Their partnership exemplifies the collaborative spirit often found in scientific innovation.
Conclusion
Philippe Leissner's contributions to adenovirus research highlight his role as an inventor in the biotechnology sector. His innovative patent and collaboration with colleagues underscore the importance of teamwork in advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile